Annals of Epidemiology
Volume 17, Issue 5, Supplement , Pages S24-S31 , May 2007

Mechanism by which Alcohol and Wine Polyphenols Affect Coronary Heart Disease Risk

References 

  1. Barnett E, Halverson J. Local increases in coronary heart disease mortality among blacks and whites in the United States, 1985–1995. Am J Public Health. 2001;91:1499–1506
  2. Jousilahti P, Salomaa V, Kuulasmaa K, Niemela M, Vartiainen E. Total and cause specific mortality among participants and non-participants of population based health surveys: a comprehensive follow up of 54 372 Finnish men and women. J Epidemiol Community Health. 2005;59:310–315
  3. Bakx C, Schwarte J, van den Hoogen H, Bor H, van Weel C. First myocardial infarction in a Dutch general practice population: trends in incidence from 1975–2003. Br J Gen Pract. 2005;55:860–863
  4. Machado DB, Crow RS, Boland LL, Hannan PJ, Taylor HA, Folsom AR. Electrocardiographic findings and incident coronary heart disease among participants in the atherosclerosis risk in communities (ARIC) Study. Am J Cardiol. 2006;97:1176–1181
  5. Goldberg RJ, Glatfelter K, Burbank-Schmidt E, Lessard D, Gore JM. Trends in community mortality due to coronary heart disease. Am Heart J. 2006;151:501–507
  6. Doll R, Peto R, Hall E, Wheatley K, Gray R. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors.. [see comment] BMJ. 1994;309:911–918
  7. Theobald H, Bygren LO, Carstensen J, Engfeldt P. A moderate intake of wine is associated with reduced total mortality and reduced mortality from cardiovascular disease. J Stud Alcohol. 2000;61:652–656
  8. Ruf JC. Overview of epidemiological studies on wine, health and mortality. Drugs Exp Clin Res. 2003;29:173–179
  9. Wellmann J, Heidrich J, Berger K, Doring A, Heuschmann PU, Keil U. Changes in alcohol intake and risk of coronary heart disease and all-cause mortality in the MONICA/KORA-Augsburg cohort 1987–97. Eur J Cardiovasc Prev Rehabil. 2004;11:48–55
  10. Renaud SC, Gueguen R, Conard P, Lanzmann-Petithory D, Orgogozo JM, Henry O. Moderate wine drinkers have lower hypertension-related mortality: a prospective cohort study in French men. Am J Clin Nutr. 2004;80:621–625
  11. Mansvelt EP, van Velden DP, Fourie E, Rossouw M, van Rensburg SJ, Smuts CM. The in vivo antithrombotic effect of wine consumption on human blood platelets and hemostatic factors. Ann N Y Acad Sci. 2002;957:329–332
  12. de Lorgeril M, Salen P, Martin JL, Boucher F, Paillard F, de Leiris J. Wine drinking and risks of cardiovascular complications after recent acute myocardial infarction. [see comment] Circulation. 2002;106:1465–1469
  13. Fernandez-Jarne E, Martinez-Losa E, Serrano-Martinez M, Prado-Santamaria M, Brugarolas-Brufau C, Martinez-Gonzalez MA. Type of alcoholic beverage and first acute myocardial infarction: a case-control study in a Mediterranean country. Clin Cardiol. 2003;26:313–318
  14. Augustin LS, Gallus S, Tavani A, Bosetti C, Negri E, La VC. Alcohol consumption and acute myocardial infarction: a benefit of alcohol consumed with meals?. Epidemiology. 2004;15:767–769
  15. Suh I, Shaten J, Cutler JA, Kuller LH. The Multiple Risk Factor Intervention Trial Research Group. Alcohol use and mortality form coronary heart disease: the role of high-density lipoprotein cholesterol. Ann Intern Med. 1992;116:881–887
  16. Renaud S, Lanzmann-Petithory D, Gueguen R, Conard P. Alcohol and mortality from all causes. Biol Res. 2004;37:183–187
  17. Mukamal KJ, Jensen MK, Grønbæk M, Stampfer MJ, Manson JE, Pischon T, et al. Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation. 2005;112:1406–1413
  18. Zhang QH, Das K, Siddiqui S, Myers AK. Effects of acute, moderate ethanol consumption on human platelet aggregation in platelet-rich plasma and whole blood. Alcohol Clin Exp Res. 2000;24:528–534
  19. Ruf JC. Alcohol, wine and platelet function. Biol Res. 2004;37:209–215
  20. Miyamae M, Diamond I, Weiner MW, Camacho SA, Figueredo VM. Regular alcohol consumption mimics cardiac preconditioning by protecting against ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 1997;94:3235–3239
  21. Guiraud A, de Lorgeril M, Boucher F, Berthonneche C, Rakotovao A, de Leiris J. Cardioprotective effect of chronic low dose ethanol drinking: insights into the concept of ethanol preconditioning. J Mol Cell Cardiol. 2004;36:561–566
  22. Rendig SV, Symons JD, Longhurst JC, Amsterdam EA. Effects of red wine, alcohol, and quercetin on coronary resistance and conductance arteries. J Cardiovasc Pharmacol. 2001;38:219–227
  23. Liu J, Tian Z, Gao B, Kunos G. Dose-dependent activation of antiapoptotic and proapoptotic pathways by ethanol treatment in human vascular endothelial cells. differential involvement of adenosine. J Biol Chem. 2002;277:20927–20933
  24. Salem RO, Laposata M. Effects of alcohol on hemostasis. Am J Clin Pathol. 2005;123(Suppl):S96–S105
  25. Wang Z, Barker TH, Fuller GM. Alcohol at moderate levels decrease fibrinogen expression in vivo and in vitro. Alcohol Clin Exp Res. 1999;23:1927–1932
  26. Ridker PM, Vaughan DE, Stampfer MJ, Glynn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 1994;272:929–933
  27. Veenstra J, te Wierik E, Kluft C. Alcohol and fibrinolysis. Fibrinolysis. 1995;4:64–67
  28. Aikens ML, Benza RL, Grenett HE, Tabengwa EM, Davis GC, Demissie S, et al. Ethanol increases surface-localized fibrinolytic activity in cultured endothelial cells. Alcohol Clin Exp Res. 1997;21:1471–1478
  29. Abou-Agag LH, Tabengwa EM, Tresnak JA, Wheeler CG, Taylor KB, Booyse FM. Ethanol-induced increased surface-localized fibrinolytic activity in cultured human endothelial cells: kinetic analysis. Alcohol Clin Exp Res. 2001;25:351–361
  30. Lee KW, Lip GY. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med. 2003;163:2368–2392
  31. de Lange DW, van de Wiel A. Drink to prevent: review on the cardioprotective mechanisms of alcohol and red wine polyphenols. Semin Vasc Med. 2004;4:173–186
  32. Guillaume P, Jankowski M, Gutkowska J, Gianoulakis C. Effect of chronic moderate ethanol consumption on heart brain natriuretic peptide. Eur J Pharmacol. 1996;316:49–58
  33. Emeson EE, Manaves V, Emeson BS, Chen L, Jovanovic I. Alcohol inhibits the progression as well as the initiation of atherosclerotic lesions in C57Bl/6 hyperlipidemic mice. Alcohol Clin Exp Res. 2000;24(9):1456–1466
  34. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med. 1996;125:384–389
  35. Flesch M, Schwarz A, Bohm M. Effects of red and white wine on endothelium-dependent vasorelaxation of rat aorta and human coronary arteries. Am J Physiol. 1998;275:H1183–H1190
  36. Andriambeloson E, Stoclet JC, Andriantsitohaina R. Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. J Cardiovasc Pharmacol. 1999;33:248–254
  37. Rakici O, Kiziltepe U, Coskun B, Aslamaci S, Akar F. Effects of resveratrol on vascular tone and endothelial function of human saphenous vein and internal mammary artery. Int J Cardiol. 2005;105:209–215
  38. Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Coleman R, et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol. 1997;17:2744–2752
  39. Aviram M, Fuhrman B. Wine flavonoids protect against LDL oxidation and atherosclerosis 3. Ann N Y Acad Sci. 2002;957:146–161
  40. Corder R, Douthwaite JA, Lees DM, Khan NQ, Viseu Dos Santos AC, Wood EG, et al. Endothelin-1 synthesis reduced by red wine. Nature. 2001;414:863–864
  41. Stoclet JC, Chataigneau T, Ndiaye M, Oak MH, El Bedoui J, Chataigneau M, et al. Vascular protection by dietary polyphenols. Eur J Pharmacol. 2004;500:299–313
  42. Di Santo A, Mezzetti A, Napoleone E, Di Tommaso R, Donati MB, de Gaetano G, et al. Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells. J Thromb Haemost. 2003;1:1089–1095
  43. Casani L, Segales E, Vilahur G, Bayes de Luna A, Badimon L. Moderate daily intake of red wine inhibits mural thrombosis and monocyte tissue factor expression in an experimental porcine model. Circulation. 2004;110:460–465
  44. Di Santo A, Mezzetti A, Napoleone E, Di Tommaso R, Donati MB, de Gaetano G, et al. Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells. J Thromb Haemost. 2003;1:1089–1095
  45. De Curtis A, Murzilli S, Di Castelnuovo A, Rotilio D, Donati MB, de Gaetano G, et al. Alcohol-free red wine prevents arterial thrombosis in dietary-induced hypercholesterolemic rats: experimental support for the ‘French paradox’. J Thromb Haemost. 2005;3:346–350
  46. Zern TL, Fernandez ML. Cardioprotective effects of dietary polyphenols. J Nutr. 2005;135:2291–2294
  47. Avellone G, Di Garbo V, Campisi D, De Simone R, Raneli G, Scaglione R, et al. Effects of moderate Sicilian red wine consumption on inflammatory biomarkers of atherosclerosis. Eur J Clin Nutr. 2006;60:41–47
  48. Bucki R, Pastore JJ, Giraud F, Sulpice JC, Janmey PA. Flavonoid inhibition of platelet procoagulant activity and phosphoinositide synthesis. J Thromb Haemost. 2003;1:1820–1828
  49. Hubbard GP, Wolffram S, Lovegrove JA, Gibbins JM. Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost. 2004;2:2138–2145
  50. Iijima K, Yoshizumi M, Hashimoto M, Kim S, Eto M, Ako J, et al. Red wine polyphenols inhibit proliferation of vascular smooth muscle cells and downregulate expression of cyclin A gene. Circulation. 2000;101:805–811
  51. Alcocer F, Whitley D, Salazar-Gonzalez JF, Jordan WD, Sellers MT, Eckhoff DE, et al. Quercetin inhibits human vascular smooth muscle cell proliferation and migration. Surgery. 2002;131:198–204
  52. Zhao X, Gu Z, Attele AS, Yuan CS. Effects of quercetin on the release of endothelin, prostacyclin and tissue plasminogen activator from human endothelial cells in culture. J Ethnopharmacol. 1999;67:279–285
  53. Abou-Agag LH, Aikens ML, Tabengwa EM, Benza RL, Shows SR, Grenett HE, et al. Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells. Alcohol Clin Exp Res. 2001;25:155–162
  54. Lijnen HR. Elements of the fibrinolytic system. Ann N Y Acad Sci. 2001;936:226–236
  55. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest. 1991;88:1067–1072
  56. Lijnen HR, Collen D. Mechanisms of physiological fibrinolysis. Baillieres Clin Haematol. 1995;8:277–289
  57. Cesarman GM, Guevara CA, Hajjar KA. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activator. J Biol Chem. 1994;269:21198–21203
  58. Barnathan ES. Characterization and regulation of the urokinase receptor of human endothelial cells. Fibrinolysis. 1992;6:1–9
  59. Laug WE. Ethyl alcohol enhances plasminogen activator secretion by endothelial cells. JAMA. 1983;250:772–776
  60. Venkov CD, Su M, Shry Y, Vaughan DE. Ethanol-induced alterations in the expression of endothelial-derived fibrinolytic components. Fibrinol Proteol. 1997;11(2):115–118
  61. Miyamoto A, Yang SX, Laufs U, Ruan XL, Liao JK. Activation of guanine nucleotide-binding proteins and induction of endothelial tissue-type plasminogen activator gene transcription by alcohol. J Biol Chem. 1999;274:12055–12060
  62. Aikens ML, Grenett HE, Benza RL, Tabengwa EM, Davis GC, Booyse FM. Alcohol-induced up-regulation of plasminogen activators and fibrinolytic activity in cultured human endothelial cells. Alcohol Clin Exp Res. 1998;22:375–381
  63. Grenett HE, Aikens ML, Torres JA, Demissie S, Tabengwa EM, Davis GC, et al. Ethanol transcriptionally upregulates t-PA and u-PA gene expression in cultured human endothelial cells. Alcohol Clin Exp Res. 1998;22:849–853
  64. Tabengwa EM, Abou-Agag LH, Benza RL, Torres JA, Aikens ML, Booyse FM. Ethanol-induced up-regulation of candidate plasminogen receptor annexin II in cultured human endothelial cells. Alcohol Clin Exp Res. 2000;24:754–761
  65. Tabengwa EM, Grenett HE, Benza RL, Abou-Agag LH, Tresnak JK, Wheeler CG, et al. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells. Alcohol Clin Exp Res. 2001;25:163–170
  66. Grenett HE, Aikens ML, Tabengwa EM, Davis GC, Booyse FM. Ethanol downregulates transcription of the PAI-1 gene in cultured human endothelial cells. Thromb Res. 2000;97:247–255
  67. Grenett HE, Wolkowicz PE, Benza RL, Tresnak JK, Wheeler And CG, Booyse FM. Identification of a 251-bp fragment of the PAI-1 gene promoter that mediates the ethanol-induced suppression of PAI-1 expression. Alcohol Clin Exp Res. 2001;25:629–636
  68. Tabengwa EM, Drawz SL, Pan W, Grenett HE, Booyse FM. Wine components activate t-PA gene transcription through the JNK and p38 mitogen activated protein kinase pathways. J Am Coll Cardiol. 2005;45(3 Suppl A):367A
  69. Pan W, Booyse FM, Grenett HE, Pasten MC, Drawz SL, Tabengwa EM. Alcohol induction of tissue plasminogen activator expression in human endothelial cells through Sp1 and NFkappaB activation: involvement of p38 MAPK pathway. Arterioscler Thromb Vasc Biol. In press.
  70. Pan W, Booyse FM, Bradley KM, Tabengwa EM. Transcriptional activation of tissue plasminogen activator by dietary polyphenols catechin and quercetin is mediated through Sp1 and NFkappaB: involvement of p38 MAPK pathway. Arterioscler Thromb Vasc Biol. In press.
  71. Bdeir K, Murciano JC, Tomaszewski J, Koniaris L, Martinez J, Cines DB, et al. Urokinase mediates fibrinolysis in the pulmonary microvasculature. Blood. 2000;96:1820–1826
  72. Pan W, Booyse FM, Grenett HE, Parks DA, Zinn K, Tabengwa EM. Development of a real-time fluorescence imaging in vivo clot lysis method: alcohol- and polyphenol (catechin and quercetin)-induced effects. Thromb Haemost. In press.

 This work has been supported, in part, by Grant HL070610 (National Heart, Lung and Blood Institute) and Grant AA 11674 (National Institute on Alcohol Abuse and Alcoholism).

PII: S1047-2797(07)00008-7

doi: 10.1016/j.annepidem.2007.01.006

Annals of Epidemiology
Volume 17, Issue 5, Supplement , Pages S24-S31 , May 2007

Article Tools

* Image Usage & Resolution